Leike P. Zhang

State Key Laboratory Of Drug Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 110 publications

Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations

Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: May 20, 2026

SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir.

SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir.

Journal: Journal of virology

Published: April 27, 2026

The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.

The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.

Journal: Journal of virology

Published: April 21, 2026

The 516th case: hyperinflammatory state, acute renal dysfunction, hepatosplenomegaly with lymphadenopathy, and recurrent cerebral infarctions

The 516th case: hyperinflammatory state, acute renal dysfunction, hepatosplenomegaly with lymphadenopathy, and recurrent cerebral infarctions

Journal: Zhonghua nei ke za zhi

Published: April 06, 2026

Recent progress in anti-Chikungunya virus drug discovery: Focus on the viral life cycle and direct-acting antivirals.

Recent progress in anti-Chikungunya virus drug discovery: Focus on the viral life cycle and direct-acting antivirals.

Journal: Virologica Sinica

Published: February 28, 2026

Oral VV261 administration protects mice from lethal Crimean-Congo hemorrhagic fever virus challenge.

Oral VV261 administration protects mice from lethal Crimean-Congo hemorrhagic fever virus challenge.

Journal: Journal of virology

Published: November 25, 2025

The oral nucleoside drug VV116 is a promising candidate for treating Nipah virus infection.

The oral nucleoside drug VV116 is a promising candidate for treating Nipah virus infection.

Journal: Emerging microbes & infections

Published: November 19, 2025

Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.

Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.

Journal: Signal transduction and targeted therapy

Published: September 25, 2025

An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.

An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.

Journal: Journal of virology

Published: September 16, 2025

Severe fever with thrombocytopenia syndrome virus infection of the male reproductive tract induces pathology and inflammation.

Severe fever with thrombocytopenia syndrome virus infection of the male reproductive tract induces pathology and inflammation.

Journal: Nature microbiology

Published: August 09, 2025

Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors.

Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 04, 2025

The impact of myocardial infarct size dynamics on left ventricular remodeling in STEMI patients after primary percutaneous coronary intervention

The impact of myocardial infarct size dynamics on left ventricular remodeling in STEMI patients after primary percutaneous coronary intervention

Journal: Zhonghua xin xue guan bing za zhi

Published: June 18, 2025

Showing 1-12 of 110

Last Updated: 09/26/2026